KA stock forecast
Our latest prediction for Kineta Inc's stock price was made on the Sept. 25, 2023 when the stock price was at 2.49$.
In the short term (2weeks), KA's stock price should underperform the market by -3.01%. During that period the price should oscillate between -10.96% and +6.82%.
In the medium term (3months), KA's stock price should underperform the market by -2.88%. During that period the price should oscillate between -28.62% and +24.37%.
Get email alertsCreate a solid portfolio with KA
About Kineta Inc
proteostasis therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, or proteostasis network. the proteostasis network maintains the body’s natural balance of proteins to protect us from numerous diseases. these novel therapies, or proteostasis regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the proteostasis network, such as alzheimer’s disease, emphysema, huntington’s disease, and type ii diabetes.
At the moment the company generates 17M USD in revenues.
On its last earning announcement, the company reported a loss of -9.51$ per share.
The book value per share is 0.50$
Three months stock forecastSept. 25, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17M | 27.11% | -31M | -180.31% | -51M | -9.51 | - | - | 9M | 0.50 | - | - | - |